spacer
spacer

PDBsum entry 4cdq

Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Virus PDB id
4cdq

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
297 a.a.
245 a.a.
242 a.a.
58 a.a.
Ligands
7VR
Metals
_NA
Waters ×102
PDB id:
4cdq
Name: Virus
Title: Crystal structure of human enterovirus 71 in complex with the uncoating inhibitor gpp2
Structure: Vp1. Chain: a. Engineered: yes. Vp2. Chain: b. Engineered: yes. Vp3. Chain: c. Engineered: yes.
Source: Enterovirus a71. Organism_taxid: 39054. Expressed in: chlorocebus aethiops. Expression_system_taxid: 9534. Expression_system_cell_line: vero cells. Expression_system_cell_line: vero cells
Resolution:
2.65Å     R-factor:   0.245     R-free:   0.246
Authors: L.Decolibus,X.Wang,J.A.B.Spyrou,J.Kelly,J.Ren,J.Grimes,G.Puerstinger, N.Stonehouse,T.S.Walter,Z.Hu,J.Wang,X.Li,W.Peng,D.Rowlands,E.E.Fry, Z.Rao,D.I.Stuart
Key ref: L.De Colibus et al. (2014). More-powerful virus inhibitors from structure-based analysis of HEV71 capsid-binding molecules. Nat Struct Biol, 21, 282-288. PubMed id: 24509833 DOI: 10.1038/nsmb.2769
Date:
05-Nov-13     Release date:   12-Feb-14    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
B2ZUN0  (B2ZUN0_HE71) -  Genome polyprotein from Human enterovirus 71
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
2193 a.a.
297 a.a.
Protein chain
Pfam   ArchSchema ?
B2ZUN0  (B2ZUN0_HE71) -  Genome polyprotein from Human enterovirus 71
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
2193 a.a.
245 a.a.
Protein chain
Pfam   ArchSchema ?
B2ZUN0  (B2ZUN0_HE71) -  Genome polyprotein from Human enterovirus 71
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
2193 a.a.
242 a.a.
Protein chain
Pfam   ArchSchema ?
B2ZUN0  (B2ZUN0_HE71) -  Genome polyprotein from Human enterovirus 71
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
2193 a.a.
58 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class 2: Chains A, B, C, D: E.C.2.7.7.48  - RNA-directed Rna polymerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: RNA(n) + a ribonucleoside 5'-triphosphate = RNA(n+1) + diphosphate
RNA(n)
+ ribonucleoside 5'-triphosphate
= RNA(n+1)
+ diphosphate
   Enzyme class 3: Chains A, B, C, D: E.C.3.4.22.28  - picornain 3C.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Selective cleavage of Gln-|-Gly bond in the poliovirus polyprotein. In other picornavirus reactions Glu may be substituted for Gln, and Ser or Thr for Gly.
   Enzyme class 4: Chains A, B, C, D: E.C.3.4.22.29  - picornain 2A.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Selective cleavage of Tyr-|-Gly bond in the picornavirus polyprotein. In other picornavirus reactions Glu may be substituted for Gln, and Ser or Thr for Gly.
   Enzyme class 5: Chains A, B, C, D: E.C.3.6.1.15  - nucleoside-triphosphate phosphatase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: a ribonucleoside 5'-triphosphate + H2O = a ribonucleoside 5'-diphosphate + phosphate + H+
ribonucleoside 5'-triphosphate
+ H2O
= ribonucleoside 5'-diphosphate
+ phosphate
+ H(+)
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1038/nsmb.2769 Nat Struct Biol 21:282-288 (2014)
PubMed id: 24509833  
 
 
More-powerful virus inhibitors from structure-based analysis of HEV71 capsid-binding molecules.
L.De Colibus, X.Wang, J.A.Spyrou, J.Kelly, J.Ren, J.Grimes, G.Puerstinger, N.Stonehouse, T.S.Walter, Z.Hu, J.Wang, X.Li, W.Peng, D.J.Rowlands, E.E.Fry, Z.Rao, D.I.Stuart.
 
  ABSTRACT  
 
Enterovirus 71 (HEV71) epidemics in children and infants result mainly in mild symptoms; however, especially in the Asia-Pacific region, infection can be fatal. At present, no therapies are available. We have used structural analysis of the complete virus to guide the design of HEV71 inhibitors. Analysis of complexes with four 3-(4-pyridyl)-2-imidazolidinone derivatives with varying anti-HEV71 activities pinpointed key structure-activity correlates. We then identified additional potentially beneficial substitutions, developed methods to reliably triage compounds by quantum mechanics-enhanced ligand docking and synthesized two candidates. Structural analysis and in vitro assays confirmed the predicted binding modes and their ability to block viral infection. One ligand (with IC50 of 25 pM) is an order of magnitude more potent than the best previously reported inhibitor and is also more soluble. Our approach may be useful in the design of effective drugs for enterovirus infections.
 

 

spacer

spacer